-
1
-
-
84897963303
-
Global control of tuberculosis: From extensively drug-resistant to untreatable tuberculosis
-
Dheda K, Gumbo T, Gandhi NR, Murray M, Theron G, Udwadia Z, Migliori GB, Warren R. 2014. Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. Lancet Respir Med 2:321-338. http://dx.doi.org/10.1016/S2213-2600(14)70031-1.
-
(2014)
Lancet Respir Med
, vol.2
, pp. 321-338
-
-
Dheda, K.1
Gumbo, T.2
Gandhi, N.R.3
Murray, M.4
Theron, G.5
Udwadia, Z.6
Migliori, G.B.7
Warren, R.8
-
2
-
-
60749083864
-
Treatment outcomes among patients with multidrug-resistant tuberculosis: Systematic review and meta-analysis
-
Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, Gandhi NR, Galvani AP. 2009. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis 9:153-161. http://dx.doi.org/10.1016/S1473-3099(09)70041-6.
-
(2009)
Lancet Infect Dis
, vol.9
, pp. 153-161
-
-
Orenstein, E.W.1
Basu, S.2
Shah, N.S.3
Andrews, J.R.4
Friedland, G.H.5
Moll, A.P.6
Gandhi, N.R.7
Galvani, A.P.8
-
3
-
-
84893257773
-
-
WHO/HTM/20131. WHO, Geneva, Switzerland
-
WHO. 2013. Global tuberculosis report. WHO/HTM/20131. WHO, Geneva, Switzerland.
-
(2013)
Global Tuberculosis Report
-
-
WHO1
-
4
-
-
77951549958
-
Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis
-
Dartois V, Barry CE. 2010. Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis. Curr Clin Pharmacol 5:96-114. http://dx.doi.org/10.2174/157488410791110797.
-
(2010)
Curr Clin Pharmacol
, vol.5
, pp. 96-114
-
-
Dartois, V.1
Barry, C.E.2
-
5
-
-
81055143909
-
Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability
-
Srivastava S, Pasipanodya JG, Meek C, Leff R, Gumbo T. 2011. Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability. J Infect Dis 204:1951-1959. http://dx.doi.org/10.1093/infdis/jir658.
-
(2011)
J Infect Dis
, vol.204
, pp. 1951-1959
-
-
Srivastava, S.1
Pasipanodya, J.G.2
Meek, C.3
Leff, R.4
Gumbo, T.5
-
6
-
-
84885395522
-
Serum drug concentrations predictive of pulmonary tuberculosis outcomes
-
Pasipanodya JG, McIlleron H, Burger A, Wash PA, Smith P, Gumbo T. 2013. Serum drug concentrations predictive of pulmonary tuberculosis outcomes. J Infect Dis 208:1464-1473. http://dx.doi.org/10.1093/infdis/jit352.
-
(2013)
J Infect Dis
, vol.208
, pp. 1464-1473
-
-
Pasipanodya, J.G.1
McIlleron, H.2
Burger, A.3
Wash, P.A.4
Smith, P.5
Gumbo, T.6
-
7
-
-
66949172863
-
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana
-
Chideya S, Winston CA, Peloquin CA, Bradford WZ, Hopewell PC, Wells CD, Reingold AL, Kenyon TA, Moeti TL, Tappero JW. 2009. Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana. Clin Infect Dis 48:1685-1694. http://dx.doi.org/10.1086/599040.
-
(2009)
Clin Infect Dis
, vol.48
, pp. 1685-1694
-
-
Chideya, S.1
Winston, C.A.2
Peloquin, C.A.3
Bradford, W.Z.4
Hopewell, P.C.5
Wells, C.D.6
Reingold, A.L.7
Kenyon, T.A.8
Moeti, T.L.9
Tappero, J.W.10
-
8
-
-
84893469977
-
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis
-
Mpagama SG, Ndusilo N, Stroup S, Kumburu H, Peloquin CA, Gratz J, Houpt ER, Kibiki GS, Heysell SK. 2014. Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis. Antimicrob Agents Chemother 58:782-788. http://dx.doi.org/10.1128/AAC.01549-13.
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 782-788
-
-
Mpagama, S.G.1
Ndusilo, N.2
Stroup, S.3
Kumburu, H.4
Peloquin, C.A.5
Gratz, J.6
Houpt, E.R.7
Kibiki, G.S.8
Heysell, S.K.9
-
9
-
-
84890035959
-
Drug concentration in lung tissue in multidrug-resistant tuberculosis
-
Akkerman OW, van Altena R, Klinkenberg T, Brouwers AH, Bongaerts AH, van der Werf TS, Alffenaar JW. 2013. Drug concentration in lung tissue in multidrug-resistant tuberculosis. Eur Respir J 42:1750-1752. http://dx.doi.org/10.1183/09031936.00047413.
-
(2013)
Eur Respir J
, vol.42
, pp. 1750-1752
-
-
Akkerman, O.W.1
Van Altena, R.2
Klinkenberg, T.3
Brouwers, A.H.4
Bongaerts, A.H.5
Van Der Werf, T.S.6
Alffenaar, J.W.7
-
10
-
-
84856152250
-
Surgical treatment of drug-resistant tuberculosis
-
Kempker RR, Vashakidze S, Solomonia N, Dzidzikashvili N, Blumberg HM. 2012. Surgical treatment of drug-resistant tuberculosis. Lancet Infect Dis 12:157-166. http://dx.doi.org/10.1016/S1473-3099(11)70244-4.
-
(2012)
Lancet Infect Dis
, vol.12
, pp. 157-166
-
-
Kempker, R.R.1
Vashakidze, S.2
Solomonia, N.3
Dzidzikashvili, N.4
Blumberg, H.M.5
-
11
-
-
79960448247
-
Pulmonary resection for patients with multidrug-resistant tuberculosis: Systematic review and meta-analysis
-
Xu HB, Jiang RH, Li L. 2011. Pulmonary resection for patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. J Antimicrob Chemother 66:1687-1695. http://dx.doi.org/10.1093/jac/dkr210.
-
(2011)
J Antimicrob Chemother
, vol.66
, pp. 1687-1695
-
-
Xu, H.B.1
Jiang, R.H.2
Li, L.3
-
12
-
-
84857552237
-
Additional drug resistance in Mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosis
-
Kempker RR, Rabin AS, Nikolaishvili K, Kalandadze I, Gogishvili S, Blumberg HM, Vashakidze S. 2012. Additional drug resistance in Mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosis. Clin Infect Dis 54:e51-54. http://dx.doi.org/10.1093/cid/cir904.
-
(2012)
Clin Infect Dis
, vol.54
, pp. e51-e54
-
-
Kempker, R.R.1
Rabin, A.S.2
Nikolaishvili, K.3
Kalandadze, I.4
Gogishvili, S.5
Blumberg, H.M.6
Vashakidze, S.7
-
13
-
-
84878238939
-
Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery
-
Vashakidze S, Gogishvili S, Nikolaishvili K, Dzidzikashvili N, Tukvadze N, Blumberg HM, Kempker RR. 2013. Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery. Ann Thorac Surg 95:1892-1898. http://dx.doi.org/10.1016/j.athoracsur.2013.03.067.
-
(2013)
Ann Thorac Surg
, vol.95
, pp. 1892-1898
-
-
Vashakidze, S.1
Gogishvili, S.2
Nikolaishvili, K.3
Dzidzikashvili, N.4
Tukvadze, N.5
Blumberg, H.M.6
Kempker, R.R.7
-
14
-
-
34247345843
-
AAPS-FDA Workshop white paper: Microdialysis principles, application, and regulatory perspectives
-
Chaurasia CS, Muller M, Bashaw ED, Benfeldt E, Bolinder J, Bullock R, Bungay PM, DeLange EC, Derendorf H, Elmquist WF, Hammarlund-Udenaes M, Joukhadar C, Kellogg DL, Jr, Lunte CE, Nordstrom CH, Rollema H, Sawchuk RJ, Cheung BW, Shah VP, Stahle L, Ungerstedt U, Welty DF, Yeo H. 2007. AAPS-FDA Workshop white paper: microdialysis principles, application, and regulatory perspectives. J Clin Pharmacol 47:589-603. http://dx.doi.org/10.1177/0091270006299091.
-
(2007)
J Clin Pharmacol
, vol.47
, pp. 589-603
-
-
Chaurasia, C.S.1
Muller, M.2
Bashaw, E.D.3
Benfeldt, E.4
Bolinder, J.5
Bullock, R.6
Bungay, P.M.7
DeLange, E.C.8
Derendorf, H.9
Elmquist, W.F.10
Hammarlund-Udenaes, M.11
Joukhadar, C.12
Kellogg, D.L.13
Lunte, C.E.14
Nordstrom, C.H.15
Rollema, H.16
Sawchuk, R.J.17
Cheung, B.W.18
Shah, V.P.19
Stahle, L.20
Ungerstedt, U.21
Welty, D.F.22
Yeo, H.23
more..
-
15
-
-
84896724452
-
Role of microdialysis in pharmacokinetics and pharmacodynamics: Current status and future directions
-
Azeredo FJ, Dalla Costa T, Derendorf H. 2014. Role of microdialysis in pharmacokinetics and pharmacodynamics: current status and future directions. Clin Pharmacokinet 53:205-212. http://dx.doi.org/10.1007/s40262-014-0131-8.
-
(2014)
Clin Pharmacokinet
, vol.53
, pp. 205-212
-
-
Azeredo, F.J.1
Dalla Costa, T.2
Derendorf, H.3
-
17
-
-
33744924880
-
Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis
-
Johnson JL, Hadad DJ, Boom WH, Daley CL, Peloquin CA, Eisenach KD, Jankus DD, Debanne SM, Charlebois ED, Maciel E, Palaci M, Dietze R. 2006. Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis 10:605-612.
-
(2006)
Int J Tuberc Lung Dis
, vol.10
, pp. 605-612
-
-
Johnson, J.L.1
Hadad, D.J.2
Boom, W.H.3
Daley, C.L.4
Peloquin, C.A.5
Eisenach, K.D.6
Jankus, D.D.7
Debanne, S.M.8
Charlebois, E.D.9
Maciel, E.10
Palaci, M.11
Dietze, R.12
-
18
-
-
40549084636
-
Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis
-
Peloquin CA, Hadad DJ, Molino LP, Palaci M, Boom WH, Dietze R, Johnson JL. 2008. Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis. Antimicrob Agents Chemother 52:852-857. http://dx.doi.org/10.1128/AAC.01036-07.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 852-857
-
-
Peloquin, C.A.1
Hadad, D.J.2
Molino, L.P.3
Palaci, M.4
Boom, W.H.5
Dietze, R.6
Johnson, J.L.7
-
19
-
-
0032937715
-
Methods and issues in microdialysis calibration
-
Stenken JA. 1999. Methods and issues in microdialysis calibration. Anal Chim Acta 379:337-358. http://dx.doi.org/10.1016/S0003-2670(98)00598-4.
-
(1999)
Anal Chim Acta
, vol.379
, pp. 337-358
-
-
Stenken, J.A.1
-
20
-
-
0023627577
-
A microdialysis method allowing characterization of intercellular water space in humans
-
Lonnroth P, Jansson PA, Smith U. 1987. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 253:E228-231.
-
(1987)
Am J Physiol
, vol.253
, pp. E228-E231
-
-
Lonnroth, P.1
Jansson, P.A.2
Smith, U.3
-
21
-
-
84856778048
-
Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis
-
Tukvadze N, Kempker RR, Kalandadze I, Kurbatova E, Leonard MK, Apsindzelashvili R, Bablishvili N, Kipiani M, Blumberg HM. 2012. Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis. PLoS One 7:e31563. http://dx.doi.org/10.1371/journal.pone.0031563.
-
(2012)
PLoS One
, vol.7
, pp. e31563
-
-
Tukvadze, N.1
Kempker, R.R.2
Kalandadze, I.3
Kurbatova, E.4
Leonard, M.K.5
Apsindzelashvili, R.6
Bablishvili, N.7
Kipiani, M.8
Blumberg, H.M.9
-
22
-
-
79955055618
-
Laboratory diagnosis of tuberculosis in resource-poor countries: Challenges and opportunities
-
Parsons LM, Somoskovi A, Gutierrez C, Lee E, Paramasivan CN, Abimiku A, Spector S, Roscigno G, Nkengasong J. 2011. Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev 24:314-350. http://dx.doi.org/10.1128/CMR.00059-10.
-
(2011)
Clin Microbiol Rev
, vol.24
, pp. 314-350
-
-
Parsons, L.M.1
Somoskovi, A.2
Gutierrez, C.3
Lee, E.4
Paramasivan, C.N.5
Abimiku, A.6
Spector, S.7
Roscigno, G.8
Nkengasong, J.9
-
23
-
-
62049084378
-
Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support
-
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. 2009. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377-381. http://dx.doi.org/10.1016/j.jbi.2008.08.010.
-
(2009)
J Biomed Inform
, vol.42
, pp. 377-381
-
-
Harris, P.A.1
Taylor, R.2
Thielke, R.3
Payne, J.4
Gonzalez, N.5
Conde, J.G.6
-
24
-
-
67649381065
-
Quinolones
-
Yu VL, Edwards G, McKinnon PS, Peloquin C, Morse GD (ed), Antimicrobial agents. Esun Technologies, LLC, Pittsburgh, PA
-
Davis SL, Neuhauser MM, McKinnon PS. 2005. Quinolones, p 337-366. In Yu VL, Edwards G, McKinnon PS, Peloquin C, Morse GD (ed), Antimicrobial chemotherapy and vaccines, 2nd ed, vol II. Antimicrobial agents. Esun Technologies, LLC, Pittsburgh, PA.
-
(2005)
Antimicrobial Chemotherapy and Vaccines, 2nd Ed
, vol.2
, pp. 337-366
-
-
Davis, S.L.1
Neuhauser, M.M.2
McKinnon, P.S.3
-
25
-
-
84865541246
-
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: An individual patient data meta-analysis of 9,153 patients
-
Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, Chan ED, Chiang CY, Cox H, D'Ambrosio L, DeRiemer K, Dung NH, Enarson D, Falzon D, Flanagan K, Flood J, Garcia-Garcia ML, Gandhi N, Granich RM, Hollm-Delgado MG, Holtz TH, Iseman MD, Jarlsberg LG, Keshavjee S, Kim HR, Koh WJ, Lancaster J, Lange C, de Lange WC, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Mishustin SP, Mitnick CD, Narita M, O'Riordan P, Pai M, Palmero D, Park SK, Pasvol G, Pena J, Perez-Guzman C, Quelapio MI, Ponce-de-Leon A, et al. 2012. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med 9:e1001300. http://dx.doi.org/10.1371/journal.pmed.1001300.
-
(2012)
PLoS Med
, vol.9
, pp. e1001300
-
-
Ahuja, S.D.1
Ashkin, D.2
Avendano, M.3
Banerjee, R.4
Bauer, M.5
Bayona, J.N.6
Becerra, M.C.7
Benedetti, A.8
Burgos, M.9
Centis, R.10
Chan, E.D.11
Chiang, C.Y.12
Cox, H.13
D'Ambrosio, L.14
DeRiemer, K.15
Dung, N.H.16
Enarson, D.17
Falzon, D.18
Flanagan, K.19
Flood, J.20
Garcia-Garcia, M.L.21
Gandhi, N.22
Granich, R.M.23
Hollm-Delgado, M.G.24
Holtz, T.H.25
Iseman, M.D.26
Jarlsberg, L.G.27
Keshavjee, S.28
Kim, H.R.29
Koh, W.J.30
Lancaster, J.31
Lange, C.32
De Lange, W.C.33
Leimane, V.34
Leung, C.C.35
Li, J.36
Menzies, D.37
Migliori, G.B.38
Mishustin, S.P.39
Mitnick, C.D.40
Narita, M.41
O'Riordan, P.42
Pai, M.43
Palmero, D.44
Park, S.K.45
Pasvol, G.46
Pena, J.47
Perez-Guzman, C.48
Quelapio, M.I.49
Ponce-de-Leon, A.50
more..
-
26
-
-
33646463191
-
Time to sputum culture conversion in multidrug-resistant tuberculosis: Predictors and relationship to treatment outcome
-
Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V. 2006. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Ann Intern Med 144:650-659. http://dx.doi.org/10.7326/0003-4819-144-9-200605020-00008.
-
(2006)
Ann Intern Med
, vol.144
, pp. 650-659
-
-
Holtz, T.H.1
Sternberg, M.2
Kammerer, S.3
Laserson, K.F.4
Riekstina, V.5
Zarovska, E.6
Skripconoka, V.7
Wells, C.D.8
Leimane, V.9
-
27
-
-
51149114842
-
The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse
-
Hamilton CD, Stout JE, Goodman PC, Mosher A, Menzies R, Schluger NW, Khan A, Johnson JL, Vernon AN. 2008. The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse. Int J Tuberc Lung Dis 12:1059-1064.
-
(2008)
Int J Tuberc Lung Dis
, vol.12
, pp. 1059-1064
-
-
Hamilton, C.D.1
Stout, J.E.2
Goodman, P.C.3
Mosher, A.4
Menzies, R.5
Schluger, N.W.6
Khan, A.7
Johnson, J.L.8
Vernon, A.N.9
-
28
-
-
10744233688
-
Mycobacterium tuberculosis growth at the cavity surface: A microenvironment with failed immunity
-
Kaplan G, Post FA, Moreira AL, Wainwright H, Kreiswirth BN, Tanverdi M, Mathema B, Ramaswamy SV, Walther G, Steyn LM, Barry CE, III, Bekker LG. 2003. Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect Immun 71: 7099-7108. http://dx.doi.org/10.1128/IAI.71.12.7099-7108.2003.
-
(2003)
Infect Immun
, vol.71
, pp. 7099-7108
-
-
Kaplan, G.1
Post, F.A.2
Moreira, A.L.3
Wainwright, H.4
Kreiswirth, B.N.5
Tanverdi, M.6
Mathema, B.7
Ramaswamy, S.V.8
Walther, G.9
Steyn, L.M.10
Barry, C.E.11
Bekker, L.G.12
-
29
-
-
36048947771
-
Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis
-
Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ. 2007. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Clin Infect Dis 45:1290-1295. http://dx.doi.org/10.1086/522537.
-
(2007)
Clin Infect Dis
, vol.45
, pp. 1290-1295
-
-
Kim, H.R.1
Hwang, S.S.2
Kim, H.J.3
Lee, S.M.4
Yoo, C.G.5
Kim, Y.W.6
Han, S.K.7
Shim, Y.S.8
Yim, J.J.9
-
30
-
-
34548721551
-
The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis
-
Torun T, Tahaoglu K, Ozmen I, Sevim T, Atac G, Kir A, Gungor G, Bolukbasi Y, Maden E. 2007. The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 11:979-985.
-
(2007)
Int J Tuberc Lung Dis
, vol.11
, pp. 979-985
-
-
Torun, T.1
Tahaoglu, K.2
Ozmen, I.3
Sevim, T.4
Atac, G.5
Kir, A.6
Gungor, G.7
Bolukbasi, Y.8
Maden, E.9
-
31
-
-
0021979540
-
Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients
-
(In Russian.)
-
Kislitsyna NA. 1985. Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients. Probl Tuberk 1985:55-57. (In Russian.)
-
(1985)
Probl Tuberk
, vol.1985
, pp. 55-57
-
-
Kislitsyna, N.A.1
-
32
-
-
0019189475
-
Rifampicin and isoniazid concentration in the blood and resected lungs in tuberculosis with combined use of the preparations
-
(In Russian.)
-
Kislitsyna NA, Kotova NI. 1980. Rifampicin and isoniazid concentration in the blood and resected lungs in tuberculosis with combined use of the preparations. Probl Tuberk 1980:63-65. (In Russian.)
-
(1980)
Probl Tuberk
, vol.1980
, pp. 63-65
-
-
Kislitsyna, N.A.1
Kotova, N.I.2
-
34
-
-
78249263514
-
Antimicrobial chemotherapy and lung microdialysis: A review
-
Dhanani J, Roberts JA, Chew M, Lipman J, Boots RJ, Paterson DL, Fraser JF. 2010. Antimicrobial chemotherapy and lung microdialysis: a review. Int J Antimicrob Agents 36:491-500. http://dx.doi.org/10.1016/j.ijantimicag.2010.08.013.
-
(2010)
Int J Antimicrob Agents
, vol.36
, pp. 491-500
-
-
Dhanani, J.1
Roberts, J.A.2
Chew, M.3
Lipman, J.4
Boots, R.J.5
Paterson, D.L.6
Fraser, J.F.7
-
35
-
-
78650317129
-
High extracellular levels of cefpirome in unaffected and infected lung tissue of patients
-
Lindenmann J, Kugler SA, Matzi V, Porubsky C, Maier A, Dittrich P, Graninger W, Smolle-Juttner FM, Joukhadar C. 2011. High extracellular levels of cefpirome in unaffected and infected lung tissue of patients. J Antimicrob Chemother 66:160-164. http://dx.doi.org/10.1093/jac/dkq413.
-
(2011)
J Antimicrob Chemother
, vol.66
, pp. 160-164
-
-
Lindenmann, J.1
Kugler, S.A.2
Matzi, V.3
Porubsky, C.4
Maier, A.5
Dittrich, P.6
Graninger, W.7
Smolle-Juttner, F.M.8
Joukhadar, C.9
-
36
-
-
77953712341
-
Extracellular concentrations of fosfomycin in lung tissue of septic patients
-
Matzi V, Lindenmann J, Porubsky C, Kugler SA, Maier A, Dittrich P, Smolle-Juttner FM, Joukhadar C. 2010. Extracellular concentrations of fosfomycin in lung tissue of septic patients. J Antimicrob Chemother 65: 995-998. http://dx.doi.org/10.1093/jac/dkq070.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 995-998
-
-
Matzi, V.1
Lindenmann, J.2
Porubsky, C.3
Kugler, S.A.4
Maier, A.5
Dittrich, P.6
Smolle-Juttner, F.M.7
Joukhadar, C.8
-
37
-
-
79954595692
-
High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions
-
Prideaux B, Dartois V, Staab D, Weiner DM, Goh A, Via LE, Barry CE, III, Stoeckli M. 2011. High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions. Anal Chem 83:2112-2118. http://dx.doi.org/10.1021/ac1029049.
-
(2011)
Anal Chem
, vol.83
, pp. 2112-2118
-
-
Prideaux, B.1
Dartois, V.2
Staab, D.3
Weiner, D.M.4
Goh, A.5
Via, L.E.6
Barry, C.E.7
Stoeckli, M.8
|